MBX Biosciences, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | +180.4% | +55.4% | -1,579.9% | |
| – | +567.6% | +155.6% | +66.2% | |
| – | -157.0% | – | -65.7% | |
| – | -70.7% | +577.5% | +120.7% | |
| – | +171.0% | +419.3% | -47.9% | |
| – | -100.0% | – | – | |
| – | +50.3% | +238.2% | -19.0% | |
| – | -45.2% | +198.2% | +37.8% | |
| – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.